Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications.

The global Prescription Dermatological Medications market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Prescription Dermatological Medications volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prescription Dermatological Medications market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Mylan Pharmaceuticals
Pfizer
Almirall
Bausch Health
Barrier Therapeutics
PharmaDerm
Bristol-Myers Squibb
Galderma
Novartis

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Oral
Topical

Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies